Conmed (CNMD) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Conmed Corporation  (NYSE: CNMD)
 

Conmed Growth Comparisons

Select each growth Category to receive further Information





CNMD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -0.7 % 8.19 % 10.2 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) -2.31 % -2.57 % -2.54 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 1.62 % 7.23 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) -0.17 % 1.81 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 9.77 % 10.55 % 8.67 % 13.63 %


CNMD's Growth Comparisons in III. Quarter 2026




Although the Medical Equipment & Supplies industry saw advancing Revenue by 8.19%, Conmed announced -0.7% year on year sales decline in the third quarter 2026, to $ 336 millions, and underperformed the 10.2% Revenue improvement in the Healthcare sector. Weak third quarter sales, in Medical Equipment & Supplies industry and within the Healthcare sector, were reflected in Conmed Corporation results which underperformed overall market.

Top-line fell by -2.31% from the second quarter. Average annual sales growth for Conmed is 9.77%, while S & P 500's average yearly sales increase is 13.63%, including only Businesses with the third quarter 2026 financial results.

CNMD Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Orthopedic Surgery
224.77 %
49.61 %
General Surgery
174.01 %
51.79 %
United States
168.66 %
49.56 %
EMEA
-
46.54 %
Asia Pacific
196.32 %
60.92 %
Americas (excluding the United States)
-
51.48 %
Single Reportable
-
-
Total
-0.7 %
-2.31 %


Growth Rates of CNMD's Income in the third quarter 2026


CNMD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 212.69 % 11.57 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) 2.03 % 101.75 % -12.31 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) 14.42 % 13.8 % 31.01 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) 22.9 % 3.53 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change 17.4 % 11.5 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 592.41 % -73.24 % -38.84 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) -14.2 % 25.09 % -63.29 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 14.62 % 80.61 % 9.9 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 29.98 % -1.66 % -4.66 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 37.66 % 5.35 % 8.91 % -28.64 %

CNMD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 592.41 % -74.33 % -39.18 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) -14.2 % 44.21 % 11.48 % 27.07 %
Y / Y Net Income Change (Q3 TTM) 14.62 % -0.43 % 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) 29.98 % -3.35 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth 37.66 % 4.12 % 9.09 % 23.95 %

CNMD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 633.33 % -76.11 % -38.84 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) -14.29 % -63.29 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 17.63 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 30.8 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 35.73 % -3.12 % 8.91 % -28.64 %



CNMD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 633.33 % -77.09 % -39.18 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) -14.29 % 11.48 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 30.81 % - 10.56 % 4.93 %
EPS Net 5 Year Avg. Change 36.38 % 4.12 % 9.09 % 23.95 %



Despite the -77.09% decline in Medical Equipment & Supplies industry, Conmed showed impressive surge in EPS in the third quarter by 633.33% from the same quarter a year ago, to $0.66, Healthcare sector dropped -39.18%. Despite modest earnings per share in the Medical Equipment & Supplies industry and ind the Healthcare sector, Conmed Corporation reported above average market earnings per share growth.

Sequentially company's EPS fell by -14.29% from the second quarter results. . Looking into annual growth, income per share grew by 36.38% on average in last five years, while S & P 500's including only Businesses with the third quarter 2026 reports, average yearly income per share growth is 23.95%.

CNMD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -3.65 % 47.51 % 44.7 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) 36.78 % -58.02 % -42.72 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) -10.92 % 44.19 % 19.45 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) -1.32 % 9.39 % 5.9 % 15.75 %
Free Cash Flow 5 Year Avg. Change 22.48 % 4.15 % 0.41 % 1.79 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 61.26 % -9.69 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -48.26 % 4.57 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) -8.52 % -21.9 % -19.33 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) -27.3 % 1.49 % 8.85 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) -15.52 % -1.68 % 0.98 % 23.05 %
Capital Expenditures 5 Year Avg. Change 8.76 % 8.29 % 8.63 % 14.2 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.